Clinical Trials Browser

Phase EARLY_PHASE1 × Glioblastoma × Temozolomide × Clear all

NCT06072586 2025-11-20

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Phase EARLY_PHASE1 Recruiting

Glioblastoma, Glioma

NCT06831526 2025-11-12

Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

Phase EARLY_PHASE1 Recruiting

Glioblastoma

NCT03477110 2025-05-15

Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma

Phase EARLY_PHASE1 Completed

Glioblastoma

NCT04614909 2025-02-28

Study of Pamiparib in Newly Diagnosed and rGBM

Phase EARLY_PHASE1 Active not recruiting

Glioblastoma

NCT01957956 2023-11-18

Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase EARLY_PHASE1 Completed

Glioblastoma, Gliosarcoma

NCT03291990 2021-11-19

5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme

Phase EARLY_PHASE1 Completed

Glioblastoma

NCT01907165 2018-07-20

Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide

Phase EARLY_PHASE1 Completed

Glioblastoma